122 related articles for article (PubMed ID: 19387414)
1. Hormone use and lung cancer incidence: the Rancho Bernardo cohort study.
Smith JR; Barrett-Connor E; Kritz-Silverstein D; Wingard DL; Al-Delaimy WK
Menopause; 2009; 16(5):1044-8. PubMed ID: 19387414
[TBL] [Abstract][Full Text] [Related]
2. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E
Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort.
Rodriguez C; Spencer Feigelson H; Deka A; Patel AV; Jacobs EJ; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):655-60. PubMed ID: 18349283
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer risk in relation to dietary acrylamide intake.
Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
J Natl Cancer Inst; 2009 May; 101(9):651-62. PubMed ID: 19401552
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy and lung cancer-specific mortality following diagnosis: the California Teachers Study.
Clague J; Reynolds P; Henderson KD; Sullivan-Halley J; Ma H; Lacey JV; Chang S; Delclos GL; Du XL; Forman MR; Bernstein L
PLoS One; 2014; 9(7):e103735. PubMed ID: 25079077
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study.
Slatore CG; Chien JW; Au DH; Satia JA; White E
J Clin Oncol; 2010 Mar; 28(9):1540-6. PubMed ID: 20159813
[TBL] [Abstract][Full Text] [Related]
7. Type A behavior pattern, heart disease risk factors, and estrogen replacement therapy in postmenopausal women: the Rancho Bernardo Study.
Buller JC; Kritz-Silverstein D; Barrett-Connor E; Wingard D
J Womens Health; 1998 Feb; 7(1):49-56. PubMed ID: 9511132
[TBL] [Abstract][Full Text] [Related]
8. The association between hormone therapy and the risk of lung cancer in postmenopausal women: a 16-year nationwide population-based study.
Wu CC; Chung CH; Tzeng NS; Wu MJ; Tsao CH; Wu TH; Chien WC; Chen HC
Menopause; 2023 May; 30(5):521-528. PubMed ID: 36854166
[TBL] [Abstract][Full Text] [Related]
9. Female reproductive factors and the risk of lung cancer in postmenopausal women: a nationwide cohort study.
Jeon KH; Shin DW; Han K; Kim D; Yoo JE; Jeong SM; Cho JH
Br J Cancer; 2020 Apr; 122(9):1417-1424. PubMed ID: 32203211
[TBL] [Abstract][Full Text] [Related]
10. Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses' Health Study.
Baik CS; Strauss GM; Speizer FE; Feskanich D
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2525-33. PubMed ID: 20739629
[TBL] [Abstract][Full Text] [Related]
11. Association of body mass index and body fat distribution with risk of lung cancer in older women.
Drinkard CR; Sellers TA; Potter JD; Zheng W; Bostick RM; Nelson CL; Folsom AR
Am J Epidemiol; 1995 Sep; 142(6):600-7. PubMed ID: 7653468
[TBL] [Abstract][Full Text] [Related]
12. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
[TBL] [Abstract][Full Text] [Related]
13. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and stroke risk in older women.
Fung MM; Barrett-Connor E; Bettencourt RR
J Womens Health; 1999 Apr; 8(3):359-64. PubMed ID: 10326990
[TBL] [Abstract][Full Text] [Related]
15. Periodontal disease severity and cancer risk in postmenopausal women: the Buffalo OsteoPerio Study.
Mai X; LaMonte MJ; Hovey KM; Freudenheim JL; Andrews CA; Genco RJ; Wactawski-Wende J
Cancer Causes Control; 2016 Feb; 27(2):217-28. PubMed ID: 26661782
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy and coronary artery calcification in asymptomatic postmenopausal women: the Rancho Bernardo Study.
Barrett-Connor E; Laughlin GA
Menopause; 2005; 12(1):40-8. PubMed ID: 15668599
[TBL] [Abstract][Full Text] [Related]
17. Female sex hormones and risk of incident abdominal aortic aneurysm in Norwegian women in the HUNT study.
Nyrønning LÅ; Videm V; Romundstad PR; Hultgren R; Mattsson E
J Vasc Surg; 2019 Nov; 70(5):1436-1445.e2. PubMed ID: 31248762
[TBL] [Abstract][Full Text] [Related]
18. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
Wang SM; Pfeiffer RM; Gierach GL; Falk RT
Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
[TBL] [Abstract][Full Text] [Related]
19. Menopausal age, postmenopausal hormone therapy and incident atrial fibrillation.
Wong JA; Rexrode KM; Sandhu RK; Moorthy MV; Conen D; Albert CM
Heart; 2017 Dec; 103(24):1954-1961. PubMed ID: 28988211
[TBL] [Abstract][Full Text] [Related]
20. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States.
Willis DB; Calle EE; Miracle-McMahill HL; Heath CW
Cancer Causes Control; 1996 Jul; 7(4):449-57. PubMed ID: 8813433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
